1
|
Yu SH, Kan ANC, To KF, Lam YL, Yan CLS, Liu APY, Ku DTL. Durable disease control with apatinib, irinotecan and temozolomide in a case of metastatic primitive myxoid mesenchymal tumour of infancy. Pediatr Blood Cancer 2023; 70:e30026. [PMID: 36441598 DOI: 10.1002/pbc.30026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/13/2022] [Revised: 08/17/2022] [Accepted: 09/08/2022] [Indexed: 11/30/2022]
Affiliation(s)
- S H Yu
- Li Ka Shing Faculty of Medicine, The University of Hong Kong, Kowloon, Hong Kong SAR
| | - Amanda N C Kan
- Department of Pathology, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR
| | - K F To
- Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong, Kowloon, Hong Kong SAR
| | - Y L Lam
- Department of Orthopaediacs and Traumatology, Queen Mary Hospital, Kowloon, Hong Kong SAR
| | - Carol L S Yan
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR
| | - Anthony P Y Liu
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.,Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Kowloon, Hong Kong SAR
| | - Dennis T L Ku
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR
| |
Collapse
|
2
|
Au CC, Leung KKY, Hon KL, Tung JKY, Yan CLS, Hui WF, Leung WY. Cullen sign in childhood malignancies. Hong Kong Med J 2021; 27:456.e1-e2. [PMID: 34949735 DOI: 10.12809/hkmj219391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Affiliation(s)
- C C Au
- Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong
| | - K K Y Leung
- Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong
| | - K L Hon
- Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong
| | - J K Y Tung
- Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
| | - C L S Yan
- Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong
| | - W F Hui
- Department of Paediatrics and Adolescent Medicine, The Hong Kong Children's Hospital, Hong Kong
| | - W Y Leung
- Department of Surgery, The Hong Kong Children's Hospital, Hong Kong
| |
Collapse
|
3
|
Feng J, Lee V, Leung AWK, Lam GKS, Chow TTW, Cheng FWT, Yan CLS, Lee CK, Yuen PMP, Li CK. Double-unit unrelated cord blood transplantation for thalassemia major: Comparison with HLA-identical sibling bone marrow transplantation. Pediatr Transplant 2021; 25:e13901. [PMID: 33136320 DOI: 10.1111/petr.13901] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/11/2020] [Revised: 09/06/2020] [Accepted: 10/05/2020] [Indexed: 12/15/2022]
Abstract
UCBT recipients with TM are at high risk of EF related to low number of stem cells and prior alloimmunization after multiple blood transfusions. Here, we evaluated the safety and efficacy of double-unit UCBT using TT-containing conditioning regimens in TM. Retrospective analysis of children who underwent double-unit UCBT for TM in the Prince of Wales Hospital between August 2007 and January 2017, and outcome of double-unit UCBT for TM was compared with outcome of HLA-matched sibling BMT. Ten patients, median age 4.2 years, received double-unit UCBT. All patients except one engrafted at a median of 19 days. None of the patients with successful engraftment had grade III or IV aGVHD. Among nine patients with successful engraftment, six of nine patients evaluable after day 100 developed cGVHD. All patients with cGVHD were well controlled after treatment with steroids and/or supportive care and maintained good quality of life. In comparison with patients receiving BMT, those given UCBT had slower platelet recovery, and more cGVHD. With a median follow-up of 272 months after BMT and 84 months after UCBT, the 8-year OS after BMT and UCBT was 92% and 90% (P = .84), whereas 8-year DFS after BMT and UCBT was 87% and 80% (P = .54). UCB could be an acceptable source of stem cells for transplantation of TM patients when HLA-matched family bone marrow donors are NA.
Collapse
Affiliation(s)
- Jianhua Feng
- Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.,Department of Paediatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
| | - Vincent Lee
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR
| | - Alex W K Leung
- Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR
| | - Grace K S Lam
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR
| | - Terry T W Chow
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR
| | - Frankie W T Cheng
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR
| | - Carol L S Yan
- Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR
| | - Cheuk Kwong Lee
- Red Cross Blood Transfusion Service, Hospital Authority, Hong Kong Cord Blood Bank, New Territories, Hong Kong SAR
| | - Patrick M P Yuen
- Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR
| | - Chi Kong Li
- Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR.,Department of Paediatrics and Adolescent Medicine, Hong Kong Children's Hospital, New Territories, Hong Kong SAR.,Hong Kong Hub of Paediatric Excellence, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR
| |
Collapse
|
4
|
Shing MMK, Ku DTL, Chan GCF, Luk CW, Yau JPW, Fu E, Yan CLS, Ling ASC. LINC-20. INFANT BRAIN TUMOURS IN HONG KONG. Neuro Oncol 2020. [PMCID: PMC7715747 DOI: 10.1093/neuonc/noaa222.455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVES To review the clinical features, pathology and survivals of infants with brain tumours. METHODS A retrospective review of the clinical findings, pathology, treatment and survival outcome in infants with brain tumours. RESULTS From 1999 to 2018, there were 507 children (<18 years) who were diagnosed to have brain tumours in Hong Kong. The patients were treated in five public hospitals. The clinical data were collected by the Hong Kong Paediatric Haematology and Oncology Study Group, and were cross-checked with the data of the Hong Kong Cancer Registry. In this group of patients, there were 36 infants (birth to 365 days of age) i.e. 7.1% of the whole group. Both benign and malignant brain tumours were included, while non-neoplastic lesions were excluded. On average, there was 1.89 cases per year. The pathology of the tumours were astrocytoma (n= 8), medulloblastoma (n=6), germ cell tumour (n=6), PNET (n=5), ATRT (n=4), choroid plexus tumours (n=3), ependymoma (n=2), craniopharyngioma (n= 1) and ganglioglioma (n= 1). These infants were treated according to their clinical conditions and prognosis, with operation, chemotherapy or both. Radiotherapy was withheld or postponed to older age. Some patients only received palliative care due to the poor neurological status or prognosis. The overall survivals of children younger than 18 years old vs infants were 67.3% (±2.3) vs 50.5%(±9.2) respectively, while the event free survivals were 64.4% (±2.4) and 43.5% (±8.8) at 10-years respectively. CONCLUSION Infants with brain tumours have different pathology and inferior outcome.
Collapse
Affiliation(s)
- Matthew M K Shing
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong, Hong Kong
| | - Dennis T L Ku
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Tuen Mun Hospital, Hong Kong, Hong Kong
| | - Godfrey C F Chan
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Queen Mary Hospital, the University of Hong Kong, Hong Kong, Hong Kong
| | - C W Luk
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Queen Elizabeth Hospital, Hong Kong, Hong Kong
| | - Jeffrey P W Yau
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Queen Elizabeth Hospital, Hong Kong, Hong Kong
| | - Eric Fu
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Queen Elizabeth Hospital, Hong Kong, Hong Kong
| | - Carol L S Yan
- Hong Kong Children’s Hospital, Hong Kong, Hong Kong
- Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong, Hong Kong
| | | |
Collapse
|
5
|
Yan CLS, Chan NCN, Lam GKS, Ng KY, Cheng CK, Li CK. A new form of thalassemia intermedia: Compound heterozygous beta thalassemia and hemoglobin Zurich. Pediatr Blood Cancer 2019; 66:e27720. [PMID: 30900795 DOI: 10.1002/pbc.27720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2019] [Accepted: 03/05/2019] [Indexed: 11/10/2022]
Affiliation(s)
- Carol L S Yan
- Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
| | - Nelson C N Chan
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Sha Tin, Hong Kong
| | - Grace K S Lam
- Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
| | - Ka Y Ng
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Sha Tin, Hong Kong
| | - Chi K Cheng
- Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Sha Tin, Hong Kong
| | - Chi-Kong Li
- Department of Pediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Sha Tin, Hong Kong
| |
Collapse
|